Tourmaline Bio CEO Scott Requadt's 2023 pay falls 42% to $2.5M
Tourmaline Bio reports 2023 executive compensation
By ExecPay News
Published: April 19, 2024
Tourmaline Bio reported fiscal year 2023 executive compensation information on April 19, 2024.
In 2023, seven executives at Tourmaline Bio received on average a compensation package of $1.5M, a 50% decrease compared to previous year.
Average pay of disclosed executives at Tourmaline Bio
Scott Requadt, Chief Executive Officer, received $2.5M in total, which decreased by 42% compared to 2022.
Sandeep Kulkarni, Chief Executive Officer, received a compensation package of $2.1M. 86% of the compensation package, or $1.8M, was in option awards.
Mary Kay Fenton, Chief Executive Officer, earned $1.9M in 2023, a 13% decrease compared to previous year.
Michael Zdanowski, Chief Technology Officer, received $1.3M in 2023, which decreases by 44% compared to 2022.
Nancy Krieger, Chief Medical Officer, earned $1.2M in 2023.
Yung Chyung, Chief Medical Officer, received $765K in 2023.
Kevin Johnson, Chief Regulatory Officer, earned $570K in 2023.
Related executives
Sandeep Kulkarni
Tourmaline Bio
Chief Executive Officer
Yung Chyung
Tourmaline Bio
Chief Medical Officer
Kevin Johnson
Tourmaline Bio
Chief Regulatory Officer
Mary Fenton
Tourmaline Bio
Chief Executive Officer
Scott Requadt
Tourmaline Bio
Chief Executive Officer
Nancy Krieger
Tourmaline Bio
Chief Medical Officer
Michael Zdanowski
Tourmaline Bio
Chief Technology Officer
You may also like
Source: SEC filing on April 19, 2024.